市場調査レポート
商品コード
1439660
手術用レーザー - 世界市場の考察、競合情勢、市場予測(2030年)Surgical Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
手術用レーザー - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の手術用レーザーの市場規模は、2023年に18億3,167万米ドル、2030年までに27億7,261万米ドルに達し、2024年~2030年の予測期間にCAGRで7.26%の成長が見込まれます。市場は、技術の進歩、急性疾患と慢性疾患、特に眼科疾患や腫瘍性疾患の罹患率と有病率の増加により、プラス成長を示しています。加えて、幅広い用途、低侵襲手術への選好の高まり、老年人口の増加が、2024年~2030年の予測期間の手術用レーザー市場の成長に寄与しています。
手術用レーザーの市場力学
手術用レーザー市場は、さまざまな理由により製品需要が伸びています。主な要因は、世界中の製品分野で行われている技術の進歩や製品の発売などです。
例えば2022年9月、ZEISSはZEISS VISUMAX 800を発表しました。この次世代フェムトセカンドレーザーは、デジタル接続された角膜屈折矯正ワークフローを介した容易な治療計画とデータアナリティクスにより、レーザー時間と潜在的な転写エラーを削減することで、患者と外科医の快適な体験を生み出します。
さらに、LENSARは白内障手術で使用される次世代フェムトセカンドレーザー技術、ALLY(TM)Systemを発表し、2022年のAmerican Society of Cataract and Refractive Surgery(ASCRS)年次総会で複数のデータを発表しました。LENSARは2022年第1四半期にALLYの規制当局認可のための510(k)申請を提出し、2022年後半に商業的発売を予定しています。
2020年7月、SCHWIND eye-tech solutionsはSCHWIND ATOSフェムトセカンドレーザーのCE承認を取得しました。
さらに、手術用レーザー市場は、低侵襲手術の人気の高まりにより製品需要が急増しています。開腹手術がいまだ標準ですが、手術合併症のリスクの増加や長い治癒時間といった開腹手術に関連する欠点が、低侵襲手術の発展のカタリストとして作用しました。手術用レーザーは、正確性、安定性、近代技術との統合に加え、個々の外科的専門分野特有のその他の複数の恩恵をもたらします。その結果、このようなシステムは手術の分野に革命を起こすと予測されています。このように、医療分野における手術用レーザーに関連する利点により、手術用レーザー市場の成長見通しは、2024年~2030年の予測期間に有利となる見込みです。
しかし、レーザーデバイスの高いコストやレーザーに関連する安全性の懸念などの特定の要因が、手術用レーザー市場の成長の一定の抑制要因となる可能性があります。
COVID-19パンデミックの発生は、世界中で大きな影響を与えました。COVID-19パンデミックの結果、患者は白内障や屈折矯正手術などの選択的治療を受けることを非常に避けたがりました。手術件数は大幅に減少しました。調査研究によると、2020年3月後半には、2019年の同時期よりも手術件数が25%減少し、受診患者数は世界全体でおよそ50%減少しました。ロックダウン規制が解除されると、手術用レーザーの需要はすべての専門分野で急増しました。このことが、パンデミック後の世界の手術用レーザー市場の成長加速につながっています。
手術用レーザー市場のセグメント分析
手術用レーザー市場の手術セグメントでは、CO2ガスレーザーシステムが予測期間(2024年~2030年)に高いシェアを占める見込みです。これは、これらのレーザーに関連する特徴によるものと考えられます。
この製品セグメントの大きな市場シェアは、これらのデバイスと迅速な治療を採用する患者の起因する可能性があります。CO2ガスレーザーシステムの主な利点は、相対的な効率で非常に高い出力を生成することです。そのため、主に材料加工用途に使用されています。
当レポートでは、世界の手術用レーザー市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Surgical Lasers Market By Product (Solid-State Laser Systems [Erbium Yttrium Aluminum Garnet (ER: YAG), Neodymium Yttrium Aluminum Garnet (ND: YAG), Holmium Yttrium Aluminum Garnet (HO: YAG), Others], Gas Laser Systems [Co2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and growing preference for minimally invasive surgeries
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030. The Surgical Lasers market is witnessing positive growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly ophthalmic disorders and oncological disorders. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population are thereby contributing to the growth of the Surgical Lasers market during the forecast period from 2024-2030.
Surgical Lasers Market Dynamics:
The Surgical Lasers market is witnessing a growth in product demand owing to various reasons. The key factor includes the technological advancements and product launches that are taking place in the product arena across the globe.
For instance, in September 2022, ZEISS introduced the ZEISS VISUMAX 800, the next generation femtosecond lasers that create a comfortable patient and surgeon experience by reducing laser time and potential transcription errors with easy treatment planning and data analysis via a digitally connected corneal refractive workflow.
In addition, LENSAR announced its next-generation femtosecond laser technology ALLY(TM) System, used in cataract surgery, and presented multiple data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 Annual Meeting. LENSAR expects to submit a 510(k) application for regulatory clearance of ALLY in the first quarter of 2022, with a commercial launch planned for later in 2022.
In July 2020, SCHWIND eye-tech solutions received CE approval for the SCHWIND ATOS femtosecond laser.
Moreover, the Surgical Lasers market is witnessing a surge in product demand due to the growing popularity of minimally invasive procedures. Even though open surgeries are still a norm, the disadvantages associated with open surgery such as the increased risk of procedural complications, longer healing time acted as a catalyst in the development of minimally invasive procedures. Surgical Lasers offer accuracy, stability, integration with modern technology, in addition to multiple other benefits exclusive to individual surgical specialties. As a result, such systems are expected to revolutionize the field of surgery. Thus, owing to the advantages associated with surgical lasers in the medical field, the growth prospect of the Surgical Lasers market appears to be lucrative during the forecast period from 2024-2030.
However, certain factors such as the high cost of laser devices and the safety concerns associated with lasers may be certain limiting factors of the Surgical Lasers market growth.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. Patients were highly unwilling to seek elective health treatment, such as cataracts and refractive surgery, as a result of the COVID-19 epidemic. The number of surgeries performed decreased considerably. As per the research studies, in the second half of March 2020, 25% fewer surgical operations were done than in the same time in 2019, and the number of patients seen in the clinic fell by roughly 50% globally. Once the lockdown restrictions were uplifted, the demand surged across all the specialty areas for surgical lasers. This led to accelerating the growth of the Global Surgical Lasers market post-pandemic.
Surgical Lasers Market Segment Analysis:
Surgical Lasers Market By Product (Solid-state Laser Systems [Erbium Yttrium Aluminum Garnet (Er: YAG), Neodymium Yttrium Aluminum Garnet (Nd: YAG), Holmium Yttrium Aluminum Garnet (Ho: YAG), Others], Gas Laser Systems [CO2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Procedure segment of the Surgical Lasers market, the CO2 Gas Laser Systems is estimated to hold a higher share in the Surgical Lasers market during the forecast period (2024-2030). This can be attributed to the specific features associated with these lasers.
The large market share of this product segment can be attributed to the growing patient adoption of these devices and quick treatment. The main benefit of CO2 Gas Laser Systems is that it produces very high power with relative efficiency. Hence it is used primarily for materials processing applications.
CO2 laser offers low cost per watt in addition to good beam quality. It generates high power output which ranges from a few watts to 15 KWatts.
Another major advantage of using the CO2 laser is the minimized charring with faster healing which increases patients' motivation for treatment, but caution is necessary with regard to recurrence.
Therefore, it is expected that with such advantages offered by the CO2 Gas Laser Systems, this product is expected to increase its penetration in coming years, thus this will drive the segment to grow during the forecast period, which will have a positive impact on the overall Global Surgical Lasers Market growth.
Furthermore, CO2 Gas Laser Systems are gaining commercial acceptability, which also improves market penetration. All these advantages of such devices make physicians more inclined to use CO2 Gas Laser Systems.
Hence, all the above-mentioned factors are expected to drive the segment growth of the Surgical Lasers market.
North America is expected to dominate the overall Surgical Lasers Market:
Among all the regions, North America is expected to account for the largest share in the Global Surgical Lasers market. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region are expected to aid in the growth of the North America Surgical Lasers Market.
As per CDC 2020, approximately 12 million people 40 years and over in the United States have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error.
Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries.
According to the New Plastic Surgery Statistics released by the American Society of Plastic Surgeons (ASPS) shows there were nearly a quarter-million more cosmetic procedures performed in 2018 than in the year 2017. Also, according to the ASPS annual plastic surgery statistics report, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States in 2018. The statistics also revealed a rise in new trends in body-shaping procedures, with a spike in non-invasive fat reduction, as well as surgeries such as breast augmentations and liposuction.
Hence, Minimally Invasive Surgery approaches such as the use of Surgical Lasers are gaining popularity owing to their precision and minimal invasion in the surrounding anatomy. Furthermore, Surgical Lasers are being preferred by surgeons for conducting numerous surgical procedures due to aided benefits of precision and accuracy and better chances of reproducing positive surgical outcomes which further helps in faster recovery for patients. Therefore, the Surgical Lasers market is slated to register remarkable growth during the forecast period (2024-2030) owing to the factors mentioned above.
Another factor responsible for the growth of the Surgical Lasers market is the launch of new products in the region. For instance, in March 2019, Sciton Inc., a manufacturer of aesthetic and medical laser and light source technology, launched the latest version of its flagship platform JOULE X at the American Society of Laser Medicine and Surgery (ASLMS) annual meeting in Colorado., Canada. JOULE X is a multi-device platform with customizable laser and light performance.
Thus, these factors are projected to contribute to the Surgical Lasers market during the forecast period.
The rising adoption of Surgical Lasers in the country would result in the rising demand for procedures that make use of Surgical Lasers, which in turn would provide a conducive growth environment for the United States Surgical Lasers market as well as the North American region. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Surgical Lasers market during the forecast period.
Surgical Lasers Market Key Players:
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
Recent Developmental Activities in the Surgical Lasers Market:
In September 2022, Boston Scientific announced the closure of its acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures with total revenue anticipated to be approximately $200 million for full-year 2022.
Key Takeaways from the Surgical Lasers Market Report Study
Target Audience who can be benefited from this Surgical Lasers Market Report Study
Frequently Asked Questions for the Surgical Lasers Market:
According to FDA, Surgical Lasers are devices used to precisely focus light sources to treat or remove tissues. Because lasers can focus very accurately on tiny areas, they can be used for very precise surgical work or for cutting through tissue.
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030.
The Surgical Lasers market is witnessing a positive market growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population is thereby contributing to the growth of the Surgical Lasers market.
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
North America is expected to hold the highest share in the revenue in the Surgical Lasers market during the forecast period. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region, are expected to aid in the growth of the North America Surgical Lasers Market in this region.